Suppose that ZCC was listed on NASDAQ (of course it isn't and won't be).

Then, what would be the impact on ZCC's share price be if zen3694 was approved for treatment of NUT carcinoma by the FDA?

It's always fun to dream when, now, based on the RVX plan, shareholders will have to wait until a successful BoM2 to see value from their ZCC shares (if even then).

GLTA

Toinv